Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

ClinicalTrials.gov ID: NCT01984983

Public ClinicalTrials.gov record NCT01984983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 27, 2026, 6:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I, Randomized, Observer-blind, Placebo Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered Intramuscularly or Intradermally by Electroporation to Healthy Adults

Study identification

NCT ID: NCT01984983
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Ichor Medical Systems Incorporated; Industry
Enrollment: 42 participants

Conditions and interventions

Conditions

Venezuelan Equine Encephalitis Virus Infection

Interventions

Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate Biological
0.9% saline placebo Other

Biological · Other

Eligibility (public fields only)

Age range: 18 Years to 49 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2013
Primary completion: May 31, 2014
Completion: Apr 30, 2015
Last update posted: Aug 25, 2015

2013 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Accelovance	San Diego	California	92108	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01984983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 25, 2015 · Synced Jun 27, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01984983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →